Literature DB >> 33503177

Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis.

Eduardo Carvalho de Arruda Veiga1, Paulo Ricardo Higassiaraguti Rocha2, Leonardo L Caviola3, Viviane Cunha Cardoso2, Fabricio da Silva Costa1, Maria da Conceição Pereira Saraiva4, Marco Antonio Barbieri2, Heloisa Bettiol2, Ricardo Carvalho Cavalli1.   

Abstract

Preeclampsia is a multifactorial disease. Among these factors, untreated hypertension during pregnancy can result in high morbidity and mortality rates and may also be related to the future development of cardiovascular diseases.Therefore, this systematic review aimed to determine the association of previous preeclampsia with the future development of cardiovascular diseases. Studies on the association between preeclampsia and future cardiovascular diseases published in the last 10 years (2009-2019) were identified from the PubMed/Medline (207 articles), Embase (nine articles), and Cochrane (three articles) databases using the keywords "preeclampsia" and "future cardiovascular diseases", "preeclampsia" and "future heart attack", and "preeclampsia" and "future cardiac disease". After applying the inclusion and exclusion criteria, 15 articles were analyzed by systematic review and meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The meta-analysis and the determination of the quality of the articles were conducted using RevMan software, version 5.3. Statistically significant differences were observed between the control and previous preeclampsia groups with respect to systolic blood pressure (mean difference [MD] 4.32; 95% confidence interval [95%CI] 3.65, 4.99; p<0.001), diastolic blood pressure (MD): 2.11; 95%CI: 1.68, 2.55; p<0.0001), and insulin level (MD: 2.80; 95% CI: 0.50, 5.11; p<0.001). Body mass index (MD: 2.57, 95%CI: 2.06, 3.07; p=0.0001), total cholesterol (MD: 10.39; 95%CI: 8.91, 11.87; p=0.0001), HDL (MD: 2.83; 95%CI: 2.20, 3.46; p=0.0001), and LDL (MD: 1.77; 95%CI: 0.42, 3.13; p=0.0001) also differed significantly between groups. Thus, the results of the present study showed that women with a history of preeclampsia were more likely to develop cardiovascular disease.

Entities:  

Mesh:

Year:  2021        PMID: 33503177      PMCID: PMC7798130          DOI: 10.6061/clinics/2021/e1999

Source DB:  PubMed          Journal:  Clinics (Sao Paulo)        ISSN: 1807-5932            Impact factor:   2.365


  37 in total

Review 1.  Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

Authors:  Naveed Sattar; Ian A Greer
Journal:  BMJ       Date:  2002-07-20

2.  Pregnancy complications and calculated cardiovascular risk in urban women: do we envisage an association?

Authors:  Prerna Bhasin; Satwanti Kapoor
Journal:  J Urban Health       Date:  2014-02       Impact factor: 3.671

3.  Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery.

Authors:  David A Savitz; Valery A Danilack; Beth Elston; Heather S Lipkind
Journal:  Am J Epidemiol       Date:  2014-05-30       Impact factor: 4.897

4.  Evidence for shared molecular pathways of dysregulated decidualization in preeclampsia and endometrial disorders revealed by microarray data integration.

Authors:  Maria Belen Rabaglino; Kirk P Conrad
Journal:  FASEB J       Date:  2019-08-07       Impact factor: 5.191

Review 5.  Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.

Authors:  Elizabeth Phipps; Devika Prasanna; Wunnie Brima; Belinda Jim
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 8.237

6.  Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy.

Authors:  Lauren H Theilen; Huong Meeks; Alison Fraser; M Sean Esplin; Ken R Smith; Michael W Varner
Journal:  Am J Obstet Gynecol       Date:  2018-04-07       Impact factor: 8.661

Review 7.  Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis.

Authors:  Lisa J Alma; Anouk Bokslag; Angela H E M Maas; Arie Franx; Walter J Paulus; Christianne J M de Groot
Journal:  ESC Heart Fail       Date:  2017-01-30

Review 8.  Hypertensive Disorders of Pregnancy and Subsequent Cardiovascular Disease: Current National and International Guidelines and the Need for Future Research.

Authors:  David T Gamble; Bolanle Brikinns; Phyo Kyaw Myint; Sohinee Bhattacharya
Journal:  Front Cardiovasc Med       Date:  2019-05-17

Review 9.  How to prepare and manage a systematic review and meta-analysis of clinical studies.

Authors:  James R Berstock; Michael R Whitehouse
Journal:  EFORT Open Rev       Date:  2019-05-28

10.  Socioeconomic gradient in physical activity: findings from the PERSIAN cohort study.

Authors:  Ali Kazemi Karyani; Behzad Karmi Matin; Shahin Soltani; Satar Rezaei; Moslem Soofi; Yahya Salimi; Mehdi Moradinazar; Mohammad Hajizadeh; Yahya Pasdar; Behrooz Hamzeh; Loghman Barzegar; Ali Akbar Haghdoost; Reza Malekzadeh; Hossein Poustchi; Zahra Mohammadi; Elnaz Faramarzi; Ali Reza Safarpour; Farhad Pourfarzi; Mahmood Moosazadeh; Azim Nejatizadeh; Mojtaba Farjam; Davoud Vahabzadeh; Ali Ahmadi; Fereshteh Ghorat; Jafar Ahmadi; Fariborz Mansour-Ghanaei; Mohammad Reza Mirjalili; Saeid Eslami; Najmeh Maharlouei; Seyed Mehdi Tabatabaei; Sara Sarvandian; Farid Najafi
Journal:  BMC Public Health       Date:  2019-10-21       Impact factor: 4.135

View more
  2 in total

Review 1.  Use of Race, Ethnicity, and National Origin in Studies Assessing Cardiovascular Risk in Women With a History of Hypertensive Disorders of Pregnancy.

Authors:  Amy Johnston; Victrine Tseung; Sonia R Dancey; Sarah M Visintini; Thais Coutinho; Jodi D Edwards
Journal:  CJC Open       Date:  2021-08-20

2.  Profiling of exosomal microRNAs expression in umbilical cord blood from normal and preeclampsia patients.

Authors:  Hai-Tao Pan; Xiao-Liang Shi; Min Fang; Xiang-Mei Sun; Pan-Pan Chen; Jin-Long Ding; Gui-Yu Xia; Bin Yu; Tao Zhang; Hong-Dan Zhu
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-14       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.